Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

ABSTRACT: Mizo Substance Use Disorder Oral Microbiome

PROVIDER: PRJNA1264526 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other
	SRR33613336_1.fastq.gz	Fastqsanger.gz
	SRR33613336_2.fastq.gz	Fastqsanger.gz
	SRR33613340_1.fastq.gz	Fastqsanger.gz
	SRR33613340_2.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 53

Similar Datasets

Project description:Oral Microbiome in Alcohol Use Disorder during inpatient treatment

| PRJNA659632 | ENA

Methamphetamine and Other Substance Use Disorder Genetics in Thailand

Project description:Methamphetamine and Other Substance Use Disorder Genetics in Thailand

| PRJNA955367 | ENA

Brief exposure to oral antibiotics has age-dependent effects on morphine reward and gene expression in the medial prefrontal cortex of adolescent and adult mice_2

Project description:Adolescence is a critical period for the initiation of problematic drug use, which significantly increases the risk of developing substance use disorders later in life. This heightened vulnerability is partly attributed to the immaturity of the prefrontal cortex, a brain region both essential for decision-making and implicated in drug reward. During adolescence, peripheral systems, such as the gut microbiome, also undergo substantial changes. Emerging evidence suggests that disruptions to the gut microbiome can influence gene expression and drug reward behaviors in rodent models. In this study, we investigated the effects of oral antibiotics on morphine reward and prefrontal cortical gene expression in adolescent and adult mice. Using oral antibiotics to transiently disrupt the microbiome, we found that short-term antibiotic exposure reduced morphine place preference specifically in adolescent mice. In a separate cohort, we observed that antibiotic treatment altered the transcriptomic response to morphine in the medial prefrontal cortex across all age groups. Notably, the transcriptomic changes induced by antibiotics and morphine were age-specific, with distinct gene expression patterns observed in adolescents compared to adults. These findings establish a foundation for future research into the role of the gut microbiome in opioid reward and highlight potential gene pathways underlying age-dependent differences in opioid sensitivity.

2026-01-19 | GSE304070 | GEO

Brief exposure to oral antibiotics has age-dependent effects on morphine reward and gene expression in the medial prefrontal cortex of adolescent and adult mice_1

2025-08-01 | GSE303730 | GEO

Analysis of association between LPHN3 markers and substance use disorder

Project description:Analysis of association between LPHN3 markers and substance use disorder

| PRJNA448611 | ENA

Alterations in microbiome composition and metabolic byproducts drive behavioral and transcriptional responses to morphine

Project description:Recent evidence has demonstrated that the gut microbiome has marked effects on neuronal function and behavior. Disturbances to microbial populations within the gut have been linked to myriad models of neuropsychiatric disorders. However, the role of the microbiome in substance use disorders remains understudied. Here we show that male mice with their gut microbiome depleted by nonabsorbable antibiotics (Abx) exhibit decreased formation of morphine conditioned place preference across a range of doses (2.5-15 mg/kg), have decreased locomotor sensitization to morphine, and demonstrate marked changes in gene expression within the nucleus accumbens (NAc) in response to high-dose morphine (20 mg/kg × 7 days). Replacement of short-chain fatty acid (SCFA) metabolites, which are reduced by microbiome knockdown, reversed the behavioral and transcriptional effects of microbiome depletion. This identifies SCFA as the crucial mediators of microbiome-brain communication responsible for the effects on morphine reward caused by microbiome knockdown. These studies add important new behavioral, molecular, and mechanistic insight to the role of gut-brain signaling in substance use disorders

2023-05-18 | GSE232836 | GEO

Genetic analysis of Substance Use Disorder using the Indiana Biobank data

Project description:Genetic analysis of Substance Use Disorder using the Indiana Biobank data

| PRJNA869818 | ENA

Genetic analysis of Substance Use Disorder using the Indiana Biobank data

Project description:Genetic analysis of Substance Use Disorder using the Indiana Biobank data

| PRJNA869819 | ENA

Demographically Diverse Substance Use Disorder Cohorts of Dr. Stanley H. Weiss

Project description:Demographically Diverse Substance Use Disorder Cohorts of Dr. Stanley H. Weiss

| PRJNA671286 | ENA

Demographically Diverse Substance Use Disorder Cohorts of Dr. Stanley H. Weiss

Project description:Demographically Diverse Substance Use Disorder Cohorts of Dr. Stanley H. Weiss